Greystar buys Greenford site for giant PRS scheme

Wednesday, January 27, 2016 | Paul Norman

Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.


The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.

Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.

The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.

Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.

For entire article, click View More below.
 
Media Resources
View our PRESS KIT
Press Release Archives
  • Tuesday, March 2, 2021
    Greystar Wins 2020 PERE Global Awards in Three Categories

    Read More

  • Thursday, February 18, 2021
    Greystar acquires five purpose-built student accommodation assets across the UK for £291m

    Read More

  • Thursday, February 11, 2021
    Greystar Announces A$1.3 Billion Final Close of Greystar Australia Multifamily Venture I (“GAMV I”)

    Read More

  • Tuesday, January 19, 2021
    Cyrela, CPP Investments and Greystar Announce Partnership with SKR in Brazilian Multifamily Development Venture

    Read More

  • Friday, January 8, 2021
    CPP Investments and Greystar Real Estate Partners Form U.S. Multifamily Development Joint Venture

    Read More

View All Archives